According to the latest report by IMARC Group, titled, “Ablation Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027“, The global ablation devices market size reached US$ 4.7 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 9.1 Billion by 2027, exhibiting a growth rate (CAGR) of 11.7% during 2022-2027.
Ablation devices are medical instruments that are used in minimally invasive (MI) procedures to eliminate or excise abnormal body tissues for therapeutic purposes. They rely on an electrosurgical generator connected to bipolar electrode arrays to deliver thermal energy to tissues. They assist in producing heat by radio frequency, energy, or a laser to cause small burns. They also aid in treating several diseases, such as ophthalmic, urologic, cardiovascular, and gynecological. They are used to treat lesions that generate scar tissues and block electrical signals initiating the arrhythmia. They are also utilized in the surgical treatment of numerous chronic diseases and to eradicate cancerous tumors and kidney stones. As these devices offer various advantages, such as quicker recovery, shorter stay in the hospital, and minimal risk of infections, they find extensive applications in hospitals, ambulatory surgical centers, and clinics across the globe.
Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/ablation-devices-market/requestsample
Ablation Devices Market Trends and Drivers:
At present, the growing demand for minimally invasive (MI) procedures due to several benefits, such as lesser pain, lower operative complications, rapid recovery, and smaller cosmetic incisions, represents one of the key factors driving the market. Besides this, the rising prevalence of chronic pains, such as headaches, low back, cancer, arthritis, neurogenic, and musculoskeletal, is propelling the growth of the market around the world. In addition, governments of several countries are organizing campaigns to raise awareness among the masses about the benefits of using ablation devices, which is strengthening the growth of the market. Apart from this, there is a rise in the demand for radiofrequency (RF) ablation devices during cancer treatment across the globe. This, along with various benefits offered by radiofrequency (RF) ablation devices, such as lower side effects, lesser recovery time, and can be used on patients suffering from multiple tumors, which is bolstering the growth of the market. Moreover, there is an increase in the integration of the latest technologies in ablation devices, such as multi-needle electrodes showcasing accuracy and portability, to offer enhanced patient safety and procedural efficiency around the world. This, coupled with the growing adoption of robotic technologies, is offering a positive market outlook. Additionally, key players operating in the industry are investing in research and development (R&D) activities to introduce the DIRECTSENSE technology that provides data for measuring the ability of the tissue to respond to radiofrequency energy before physicians deliver therapy. In line with this, the increasing geriatric population, is expected to positively influencing the market worldwide.
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Ablation Devices Market 2022-2027 Competitive Analysis and Segmentation:
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
Abbott Laboratories
Angio Dynamics Inc.
AtriCure Inc.
Boston Scientific Corporation
CONMED Corporation
Elekta AB (publ)
Johnson & Johnson
Medtronic plc
Olympus Corporation
Smith & Nephew plc.
The report has segmented the market based on device technology, application and end user.
Breakup by Device Technology:
Radiofrequency Devices
Laser/Light Ablation
Ultrasound Devices
Cryoablation Devices
Others
Breakup by Application:
Cancer Treatment
Cardiovascular Disease Treatment
Ophthalmologic Treatment
Gynecological Treatment
Urological Treatment
Cosmetic Surgery
Others
Breakup by End User:
Hospitals
Ambulatory Surgical Centers
Others
Breakup by Region:
North America
Asia-Pacific
Europe
Latin America
Middle East and Africa
Ask Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/ablation-devices-market
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact us:
IMARC Group 30 N Gould St, Ste R Sheridan, WY (Wyoming) 82801 USA Website: https://www.imarcgroup.com Email: Sales@imarcgroup.com Tel No:(D) +91 120 433 0800 Americas: – +1 631 791 1145 | Africa and Europe:- +44-702-409-7331 | Asia: +91-120-433-0800